<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Inherit Metab Dis</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Inherit. Metab. Dis</journal-id>
<journal-title-group>
<journal-title>Journal of Inherited Metabolic Disease</journal-title>
</journal-title-group>
<issn pub-type="ppub">0141-8955</issn>
<issn pub-type="epub">1573-2665</issn>
<publisher>
<publisher-name>Springer Netherlands</publisher-name>
<publisher-loc>Dordrecht</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30132229</article-id>
<article-id pub-id-type="pmc">6326985</article-id>
<article-id pub-id-type="publisher-id">240</article-id>
<article-id pub-id-type="doi">10.1007/s10545-018-0240-x</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Setting the stage for a role of the postsynaptic proteome in inherited neurometabolic disorders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5265-6306</contrib-id>
<name>
<surname>Bayés</surname>
<given-names>Àlex</given-names>
</name>
<address>
<email>abayesp@santpau.cat</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<aff id="Aff1"><label>1</label>Molecular Physiology of the Synapse Laboratory, Biomedical Research Institute Sant Pau (IIB Sant Pau), C/Sant Antoni M. Claret, 167, 08025 Barcelona, Spain </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.7080.f</institution-id><institution>Universitat Autònoma de Barcelona, </institution></institution-wrap>Bellaterra, Cerdanyola del Vallès Spain </aff>
</contrib-group>
<author-notes>
<fn fn-type="com">
<p>Communicating Editor: Eva Morava</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>21</day>
<month>8</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>21</day>
<month>8</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<year>2018</year>
</pub-date>
<volume>41</volume>
<issue>6</issue>
<fpage>1093</fpage>
<lpage>1101</lpage>
<history>
<date date-type="received">
<day>1</day>
<month>3</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>26</day>
<month>7</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>2</day>
<month>8</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2018</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">Neurotransmitter diseases are a well-defined group of metabolic conditions caused, in most instances, by genes specifically expressed in the presynaptic button. Better understanding of presynaptic molecular physiology, both in normal and pathological conditions, should help develop therapeutical strategies. The clinical relevance of the presynapse in inherited metabolic disorders is in glaring contrast with that of the postsynaptic component, which so far does not seem to play a relevant role in these disorders. This is somewhat surprising, as postsynaptic proteins are known to be involved in many nervous system diseases, particularly in neurodevelopmental and psychiatric disorders. The goal of this article is to explore if defects in the sophisticated postsynaptic machinery could also have a role in neurometabolic disorders.</p>
<sec>
<title>Electronic supplementary material</title>
<p>The online version of this article (10.1007/s10545-018-0240-x) contains supplementary material, which is available to authorized users.</p>
</sec>
</abstract>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100007136</institution-id>
<institution>Secretaría de Estado de Investigación, Desarrollo e Innovación</institution>
</institution-wrap>
</funding-source>
<award-id>BFU2012-3439</award-id>
<award-id>BFU2015-69717-P</award-id>
<award-id>RYC-2011-08391</award-id>
<principal-award-recipient>
<name>
<surname>Bayés</surname>
<given-names>Àlex</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>FP7 People: Marie-Curie Actions ()</institution>
</funding-source>
<award-id>304111</award-id>
<principal-award-recipient>
<name>
<surname>Bayés</surname>
<given-names>Àlex</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© SSIEM 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Introduction</title>
<p id="Par2">Synapses are pivotal in cognition and behaviour, as they decode and store sensorial information. For this reason, they are very often involved in the pathophysiology of mental disorders. Synapses are typically divided in three compartments: the presynaptic button, the synaptic cleft and the postsynaptic element. The postsynaptic element of glutamatergic synapses, which represent the vast majority of central nervous system synapses (Beaulieu and Colonnier <xref ref-type="bibr" rid="CR9">1985</xref>; von Bohlen Und Halbach <xref ref-type="bibr" rid="CR68">2009</xref>; Defelipe et al. <xref ref-type="bibr" rid="CR19">2002</xref>), has a unique morphology, which is essential to its function. This structure was first described by Santiago Ramón y Cajal who named it ‘dendritic spine’ (Yuste <xref ref-type="bibr" rid="CR70">2015</xref>). Dendritic spines are dynamic protrusions of the postsynaptic membrane that present a bulbous head connected to the dendritic shaft through a thin neck (von Bohlen Und Halbach <xref ref-type="bibr" rid="CR68">2009</xref>). Another characteristic feature of dendritic spines is the presence of a very large protein complex beneath the postsynaptic membrane, the postsynaptic density (PSD). Recent large-scale proteomics experiments have produced a very detailed catalogue of the proteins which are present at the PSD, identifying hundreds of different proteins (Bayés and Grant <xref ref-type="bibr" rid="CR4">2009</xref>; Bayés et al. <xref ref-type="bibr" rid="CR6">2012</xref>, <xref ref-type="bibr" rid="CR8">2017</xref>; Distler et al. <xref ref-type="bibr" rid="CR20">2014</xref>; Focking et al. <xref ref-type="bibr" rid="CR26">2016</xref>; Roy et al. <xref ref-type="bibr" rid="CR58">2018</xref>). Paramount among PSD proteins are neurotransmitter receptors, which mediate the propagation of the incoming action potentials. Nevertheless, the PSD contains many other protein types, which participate in the translation of the electrical input into chemical signals, which ultimately drive the functional state of the synapse (Boeckers <xref ref-type="bibr" rid="CR13">2006</xref>; Kim and Sheng <xref ref-type="bibr" rid="CR38">2009</xref>; Sheng and Kim <xref ref-type="bibr" rid="CR60">2011</xref>; Dosemeci et al. <xref ref-type="bibr" rid="CR21">2016</xref>).</p>
<p id="Par3">Neurotransmitter disorders are a group of inherited neurometabolic syndromes that are primarily caused by an altered bioavailability of neurotransmitter at the synapse (Pearl et al. <xref ref-type="bibr" rid="CR52">2007</xref>; Hoffman and Blau <xref ref-type="bibr" rid="CR34">2014</xref>; Marecos et al. <xref ref-type="bibr" rid="CR44">2014</xref>; Ng et al. <xref ref-type="bibr" rid="CR48">2015</xref>; Cortès-Saladelafont et al. <xref ref-type="bibr" rid="CR17">2016</xref>). They are generally caused by pathogenic mutations in genes expressed at the axon terminal. These code for enzymes involved in the synthesis or degradation of neurotransmitters. Nevertheless, genes coding for proteins responsible for neurotransmitter release and reuptake have also been reported mutated in these conditions. The presynaptic space has thus an important role in neurometabolic disorders. Pathophysiological descriptions of neuronal dysfunction in many other classic inborn errors of metabolism (intoxication disorders, energy defects and complex molecule defects) have been mainly described from a presynaptic perspective. This circumstance is in strong contrast with our understanding of the postsynaptic role in neurometabolic disorders. In this article, I explore what is known about the main metabolic pathways functioning at the postsynapse and their potential relevance in the field of neurometabolic disorders.</p>
</sec>
<sec id="Sec2">
<title>Postsynaptic metabolic pathways</title>
<p id="Par4">A close inspection to the postsynaptic proteome should readily inform us about the key metabolic pathways operating in it. To achieve this purpose, I have looked for molecular pathways in a reference PSD proteome (Bayés et al. <xref ref-type="bibr" rid="CR8">2017</xref>) using the information contained in the ‘Reactome Pathways Database’ (Fabregat et al. <xref ref-type="bibr" rid="CR23">2018</xref>). The bioinformatics analysis tools provided by ‘Panther Classification System’ (Mi et al. <xref ref-type="bibr" rid="CR47">2016</xref>) have been used to identify metabolic pathways significantly enriched in the PSD, as previously reported (Bayés et al. <xref ref-type="bibr" rid="CR6">2012</xref>; Reig-Viader et al. <xref ref-type="bibr" rid="CR56">2018</xref>). If a pathway is significantly enriched in the PSD, it means that it presents a higher number of components than would be expected by chance. The vast majority of pathways that have been identified in this exercise are intracellular signal transduction pathways (see Supplementary Table <xref ref-type="media" rid="MOESM1">1</xref>), which is in accordance with our current knowledge of the molecular characteristics of the postsynaptic proteome (Boeckers <xref ref-type="bibr" rid="CR13">2006</xref>; Kim and Sheng <xref ref-type="bibr" rid="CR38">2009</xref>; Sheng and Kim <xref ref-type="bibr" rid="CR60">2011</xref>; Bayés et al. <xref ref-type="bibr" rid="CR6">2012</xref>; Dosemeci et al. <xref ref-type="bibr" rid="CR21">2016</xref>). These pathways typically involve the activation of membrane receptors, G-proteins or small GTPases that result in a series of molecular events, mostly phosphorylation cascades, which ultimately promote changes in cellular physiology. Nevertheless, a number of canonical metabolic pathways could be identified in the postsynaptic machinery. These are primarily related to the energetic and protein metabolisms (Table <xref ref-type="table" rid="Tab1">1</xref>). However, if one considers the expanded definition of inborn errors of metabolism (IEM), in which dysfunctions of protein traffic are also regarded as metabolic conditions (García-Cazorla and Saudubray, this issue), the list of postsynaptic metabolic pathways is extended (Table <xref ref-type="table" rid="Tab1">1</xref> and Fig. <xref ref-type="fig" rid="Fig1">1</xref>). Interestingly, this analysis also revealed that while the presynaptic button presents a set of specific metabolic pathways, the postsynaptic element does not seem to contain a similarly unique metabolism. With the exception of a pathway involved in the trafficking of α-amino-3-hydroxy-5-methyl-4-isoazolepropionic (AMPA) glutamate receptors, postsynaptic metabolic pathways underlay basic cellular functions. This is relevant, as it means that proteins involved in these processes are not unique to the postsynapse and thus a direct link between a mutation and a postsynaptic role in disease would not be straightforward.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Postsynaptic metabolic pathways</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Pathway name</th><th>Pathway code</th><th>Postsynaptic proteins in pathway</th></tr></thead><tbody><tr><td colspan="3">Energetic metabolism</td></tr><tr><td> Glycolysis</td><td>R-MMU-70171</td><td>9</td></tr><tr><td> Translocation of GLUT4 to the plasma membrane</td><td>R-MMU-1445148</td><td>38</td></tr><tr><td colspan="3">Protein metabolism</td></tr><tr><td> Protein translation</td><td>R-MMU-72766</td><td>62</td></tr><tr><td> Chaperonin-mediated protein folding</td><td>R-MMU-390466</td><td>22</td></tr><tr><td> Different proteasome pathways</td><td>R-MMU-5610785; R-MMU-195253; R-MMU-5610780</td><td>33</td></tr><tr><td colspan="3">Endocytosis and traffic of neurotransmitter receptors</td></tr><tr><td> Trafficking of AMPA receptors</td><td>R-MMU-399719</td><td>25</td></tr><tr><td> Clathrin-mediated endocytosis</td><td>R-MMU-8856828</td><td>43</td></tr></tbody></table></table-wrap><fig id="Fig1"><label>Fig. 1</label><caption><p>Schematic representation of a glutamatergic synapse indicating major metabolic pathways identified in the postsynaptic proteome. Proteomic evidence suggests that the glucose transporters GLUT1 and GLUT3  as well as the entire glycolytic pathway (represented as a yellow circle) would be present at the postsynaptic site. Confirmation of this observation with alternative methodological approaches would be required to confidently locate the glycolytic pathway within the PSD. Polysomes, for protein synthesis, and the proteasome, for protein degradation, are shown to represent the enrichment in the PSD of pathways related to protein metabolism. Finally, the traffic of AMPA receptors in and out of the postsynaptic membrane is also shown, indicating the endocytic zones where clathrin-mediated endocytosis of AMPA receptors occurs</p></caption><graphic id="MO1" xlink:href="10545_2018_240_Fig1_HTML"></graphic></fig></p>
<sec id="Sec3">
<title>Energetic metabolism at the postsynapse</title>
<p id="Par5">The presence at the presynaptic button of glucose transporters, glycolytic enzymes and mitochondria is well documented (Jang et al. <xref ref-type="bibr" rid="CR36">2016</xref>; Ashrafi et al. <xref ref-type="bibr" rid="CR2">2017</xref>). These importantly contribute to the energetic demands posed by presynaptic activity (Harris et al. <xref ref-type="bibr" rid="CR33">2012</xref>; Rangaraju et al. <xref ref-type="bibr" rid="CR55">2014</xref>). On the other hand, our understanding of the energetic machinery present at the postsynaptic side is by no means well established. The existence of glucose transporters and glycolytic enzymes in the postsynapse is still controversial. Furthermore, mitochondria do not have access to dendritic spines, remaining in dendritic shafts (Li et al. <xref ref-type="bibr" rid="CR43">2004</xref>; von Bohlen Und Halbach <xref ref-type="bibr" rid="CR68">2009</xref>). Actually, mitochondrial ATP is thought to freely diffuse into the spine head (von Bohlen Und Halbach <xref ref-type="bibr" rid="CR68">2009</xref>), instead of being actively transported there. This is particularly puzzling if we consider that most brain energy is consumed by synapses, and within synapses, restoring the postsynaptic membrane potential alone requires 50% of all its energetic demand (Attwell and Laughlin <xref ref-type="bibr" rid="CR3">2001</xref>; Harris et al. <xref ref-type="bibr" rid="CR33">2012</xref>).</p>
<p id="Par6">Several PSD proteomics experiments have identified glucose transporters 1 (GLUT1) and 3 (GLUT3), the former being more frequently reported (Fernandez et al. <xref ref-type="bibr" rid="CR24">2009</xref>; Bayés et al. <xref ref-type="bibr" rid="CR5">2011</xref>, <xref ref-type="bibr" rid="CR6">2012</xref>, <xref ref-type="bibr" rid="CR8">2017</xref>; Distler et al. <xref ref-type="bibr" rid="CR20">2014</xref>; Focking et al. <xref ref-type="bibr" rid="CR26">2016</xref>). Other glucose transporters are normally not found in proteomic analyses of postsynaptic preparations. Nevertheless, these studies commonly find GLUT1 and GLUT3 in low amounts, so that, without evidence from other methodological approaches, their location at the postsynapse remains somewhat uncertain. The literature on brain cells expressing GLUT1 is neither fully conclusive. While there is evidence that GLUT1 is expressed in blood vessels and astrocytes, its expression in neurons cannot be discarded (Leino et al. <xref ref-type="bibr" rid="CR42">1997</xref>; Simpson et al. <xref ref-type="bibr" rid="CR62">2007</xref>; Jurcovicova <xref ref-type="bibr" rid="CR37">2014</xref>). Instead, the expression of GLUT3 in neurons is well documented (Leino et al. <xref ref-type="bibr" rid="CR42">1997</xref>; Simpson et al. <xref ref-type="bibr" rid="CR62">2007</xref>; Jurcovicova <xref ref-type="bibr" rid="CR37">2014</xref>). The presence of GLUT3 at synapses has been confirmed by an immunofluorescence co-localisation experiment, although its precise sub-synaptic location (pre- vs. postsynaptic) could not be fully established (Ferreira et al. <xref ref-type="bibr" rid="CR25">2011</xref>).</p>
<p id="Par7">Proteomics experiments also report glycolytic enzymes at the PSD (Fernandez et al. <xref ref-type="bibr" rid="CR24">2009</xref>; Bayés et al. <xref ref-type="bibr" rid="CR5">2011</xref>, <xref ref-type="bibr" rid="CR6">2012</xref>, <xref ref-type="bibr" rid="CR8">2017</xref>; Distler et al. <xref ref-type="bibr" rid="CR20">2014</xref>; Focking et al. <xref ref-type="bibr" rid="CR26">2016</xref>). Actually, these articles usually identify the complete set of glycolytic enzymes. Nevertheless, to the best of my knowledge, the location at the PSD of glycolytic enzymes has only been proven once using other experimental approaches (Wu et al. <xref ref-type="bibr" rid="CR69">1997</xref>). In this seminal article, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was localised to the PSD by electron microscopy using specific antibodies. Furthermore, the activity of phosphoglycerate kinase (PGK), GAPDH and lactate dehydrogenase (LDH) was measured in biochemical preparations of postsynaptic densities proving that ATP can be synthesised at the PSD. This pioneer work suggests that some of the ATP consumed at the PSD would be locally produced via glycolysis, instead of coming from dendritic mitochondria. They also suggest that some postsynaptic functions require an instant and spatially controlled supply of ATP. As it occurs in synaptic vesicles, which contain both GAPDH and PGK that produce ATP in a highly localised manner for efficient neurotransmitter loading (Ikemoto et al. <xref ref-type="bibr" rid="CR35">2003</xref>). Further research will be required to completely clarify if glycolytic enzymes play a relevant function at the PSD, and if their malfunction could have a role in disease. Besides glycolysis, the pathway ‘Translocation of GLUT4 to the plasma membrane’ has also been found enriched among PSD proteins (Table <xref ref-type="table" rid="Tab1">1</xref>). Out of the 67 proteins that constitute this pathway, 38 are at the PSD, representing a sixfold enrichment from what would be expected by chance (Fisher’s exact test <italic>p</italic> = 9.5 E-14, Supplementary Table <xref ref-type="media" rid="MOESM1">1</xref>). Nonetheless, it is important to remark that GLUT4 is not found in the postsynaptic proteome, neither has it ever been localised to dendritic spines using alternative experimental approaches. Thus, these 38 proteins might be involved in the traffic of other glucose transporters.</p>
<p id="Par8">Finally, the postsynaptic proteome presents many proteins involved in the Krebs cycle and oxidative phosphorylation (see Supplementary Table <xref ref-type="media" rid="MOESM1">1</xref>), two metabolic processes that occur within mitochondria although, as has been already mentioned, these are absent from the postsynaptic compartment. Nevertheless, the presence of contaminating mitochondria in biochemical preparations of the PSD is as well documented as difficult to avoid (Carlin et al. <xref ref-type="bibr" rid="CR15">1980</xref>). Mitochondrial proteins, and the pathways they are involved in, are not considered as true components of the PSD.</p>
</sec>
<sec id="Sec4">
<title>Protein metabolism at the postsynapse</title>
<p id="Par9">Protein synthesis is required for the long-term changes in synaptic plasticity that underpin the formation of long-lasting memories (De Robertis and Bennett <xref ref-type="bibr" rid="CR18">1954</xref>; Palade and Palay <xref ref-type="bibr" rid="CR50">1954</xref>; Gray <xref ref-type="bibr" rid="CR28">1959</xref>; Martin et al. <xref ref-type="bibr" rid="CR45">2000</xref>). One of the first indications that proteins are synthesised outside the cell soma was actually obtained from the observation of polysomes at neuronal dendrites, close to postsynaptic spines (Steward and Levy <xref ref-type="bibr" rid="CR65">1982</xref>; Spacek <xref ref-type="bibr" rid="CR64">1985</xref>). Later, polysomes were shown to selectively enter dendritic spines that had been stimulated to produce a long-term potentiation (Ostroff et al. <xref ref-type="bibr" rid="CR49">2002</xref>). On the bases of all these findings, it should not come as a surprise that several molecular pathways related to protein metabolism appear as enriched at the postsynapse (Table <xref ref-type="table" rid="Tab1">1</xref> and Fig. <xref ref-type="fig" rid="Fig1">1</xref>). These include pathways involved in protein translation but also pathways important for protein turnover, such as ‘Chaperonin-mediated protein folding’ and protein degradation via the proteasome. The control of protein degradation by the ubiquitin proteasome pathway is tightly regulated at postsynaptic dendritic spines (Ehlers <xref ref-type="bibr" rid="CR22">2003</xref>). As it occurs for polysomes, the proteasome complex also displays a dynamic localisation between dendritic shafts and spines, which is under the control of synaptic activity (Bingol and Schuman <xref ref-type="bibr" rid="CR12">2006</xref>).</p>
</sec>
<sec id="Sec5">
<title>Traffic of AMPA glutamate receptors and postsynaptic endocytosis</title>
<p id="Par10">AMPA glutamate receptors (AMPAR) are the main drivers of fast excitatory neurotransmission. As a general rule, an increase in AMPAR at the synapse results in synaptic potentiation, while the opposite results in synaptic depression (Shepherd and Huganir <xref ref-type="bibr" rid="CR61">2007</xref>). Thus, their traffic in and out of the postsynaptic membrane is tightly regulated (Anggono and Huganir <xref ref-type="bibr" rid="CR1">2012</xref>). The insertion of AMPARs in the postsynaptic membrane occurs via exocytosis of cytosolic vesicles containing these receptors and later lateral diffusion towards the PSD. Similarly, endocytosis is required to remove AMPAR from the synapse. The areas of endocytosis at dendritic spines have been termed endocytic zones (Racz et al. <xref ref-type="bibr" rid="CR54">2004</xref>); these promote clathrin-mediated endocytosis of AMPARs and other cargo leaving the synapse. Proteins involved in AMPAR traffic and clathrin-mediated endocytosis are involved in the last two metabolic pathways characteristic of the postsynaptic machinery (Table <xref ref-type="table" rid="Tab1">1</xref>). Because of the specialised machinery involved in AMPAR traffic, this pathway is likely to be the only metabolic pathway really specific to the postsynaptic proteome.</p>
</sec>
</sec>
<sec id="Sec6">
<title>Postsynaptic metabolic disorders</title>
<p id="Par11">As previously introduced, neurometabolic disorders are intimately associated with presynaptic physiology. The notion of postsynaptic metabolic disorders is, at this point, rather speculative, with hardly any scientific literature supporting it. It is plausible that neurotransmitter diseases will secondarily alter postsynaptic physiology. Actually, this has already been reported for the creatine transporter deficiency, which results in increased synaptic levels of creatine and a prolonged stimulation of GABA receptors, to which the postsynaptic neuron responds by reducing the number of inhibitory synapses (Salomons et al. <xref ref-type="bibr" rid="CR59">2003</xref>). Similar pathophysiological mechanisms have been shown for the SSADHD deficiency (Pearl et al. <xref ref-type="bibr" rid="CR53">2009</xref>; Reis et al. <xref ref-type="bibr" rid="CR57">2012</xref>). Nevertheless, in this section, I wish to explore if there is evidence suggesting that primary dysfunction of the postsynaptic metabolic pathways described above could be involved in neurological conditions. To achieve this goal, we have looked for those genes coding for proteins involved in postsynaptic metabolic pathways that when mutated cause inherited brain conditions. It is important to keep in mind that most postsynaptic metabolic pathways are not exclusive to the postsynapse. Thus, their mutation will not necessarily imply a clinically relevant affectation of the postsynaptic physiology.</p>
<sec id="Sec7">
<title>Fifty-three PSD proteins involved in metabolic pathways cause inherited disease</title>
<p id="Par12">The ‘Online Mendelian Inheritance in Man’ (OMIM) database (McKusick <xref ref-type="bibr" rid="CR46">2007</xref>) was first used to identify proteins from postsynaptic metabolic pathways causing disease. I later gathered the individual symptoms that constitute these conditions from the ‘Human Phenotype Ontology’ (HPO) database (Köhler et al. <xref ref-type="bibr" rid="CR40">2017</xref>), which systematically brakes down clinical conditions into their main symptoms (or phenotypes). According to OMIM, of the 232 PSD proteins involved in postsynaptic metabolic pathways, 53 cause inherited clinical disorders. Table <xref ref-type="table" rid="Tab2">2</xref> lists these proteins with the name of the disease they are involved in. As some genes cause more than one condition, the total number of medical conditions caused by these 53 genes raises to 60.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Proteins involved in postsynaptic metabolic pathways that cause inherited diseases</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Pathway</th><th>Gene name</th><th>Disease (OMIM)</th><th>OMIM ID</th></tr></thead><tbody><tr><td colspan="4">Energetic metabolism</td></tr><tr><td colspan="4"> Glycolysis (including glucose transporters)</td></tr><tr><td></td><td>
<italic>ALDOA</italic>
</td><td>GLYCOGEN STORAGE DISEASE XII</td><td>611881</td></tr><tr><td></td><td>
<italic>HK1</italic>
</td><td>NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE</td><td>605285</td></tr><tr><td></td><td>
<italic>PFKM</italic>
</td><td>GLYCOGEN STORAGE DISEASE VII</td><td>232800</td></tr><tr><td></td><td>
<italic>SLC2A1</italic>
</td><td>GLUT1 DEFICIENCY SYNDROME 2</td><td>612126</td></tr><tr><td></td><td>
<italic>TPI1</italic>
</td><td>TRIOSEPHOSPHATE ISOMERASE DEFICIENCY</td><td>615512</td></tr><tr><td colspan="4"> Translocation of GLUT4 to the plasma membrane</td></tr><tr><td></td><td><italic>MYH9</italic> (1)</td><td>SEBASTIAN SYNDROME</td><td>605249</td></tr><tr><td></td><td>
<italic>MYO5A</italic>
</td><td>GRISCELLI SYNDROME, TYPE 1</td><td>214450</td></tr><tr><td></td><td>
<italic>TUBA4A</italic>
</td><td>AMYOTROPHIC LATERAL SCLEROSIS 22</td><td>616208</td></tr><tr><td></td><td>
<italic>TUBA8</italic>
</td><td>CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 8</td><td>613180</td></tr><tr><td></td><td>
<italic>TUBB2A</italic>
</td><td>CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5</td><td>615763</td></tr><tr><td></td><td>
<italic>TUBB2B</italic>
</td><td>CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7</td><td>610031</td></tr><tr><td></td><td>
<italic>TUBB3</italic>
</td><td>FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A</td><td>600638</td></tr><tr><td></td><td>
<italic>YWHAE</italic>
</td><td>MILLER-DIEKER LISSENCEPHALY SYNDROME</td><td>247200</td></tr><tr><td></td><td>
<italic>YWHAG</italic>
</td><td>EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56</td><td>617665</td></tr><tr><td colspan="4">Protein metabolism</td></tr><tr><td colspan="4"> Protein translation</td></tr><tr><td></td><td>
<italic>RPL21</italic>
</td><td>HYPOTRICHOSIS 12</td><td>615885</td></tr><tr><td></td><td>
<italic>RPL26</italic>
</td><td>DIAMOND-BLACKFAN ANEMIA 11</td><td>614900</td></tr><tr><td></td><td>
<italic>RPS10</italic>
</td><td>DIAMOND-BLACKFAN ANEMIA 9</td><td>613308</td></tr><tr><td></td><td>
<italic>RPS19</italic>
</td><td>DIAMOND-BLACKFAN ANEMIA 1</td><td>105650</td></tr><tr><td></td><td>
<italic>RPS28</italic>
</td><td>DIAMOND-BLACKFAN ANEMIA 15</td><td>606164</td></tr><tr><td></td><td>
<italic>RPS29</italic>
</td><td>DIAMOND-BLACKFAN ANEMIA 13</td><td>615909</td></tr><tr><td></td><td>
<italic>RPS14</italic>
</td><td>CHROMOSOME 5q DELETION SYNDROME</td><td>153550</td></tr><tr><td></td><td>
<italic>RPL11</italic>
</td><td>DIAMOND-BLACKFAN ANEMIA 7</td><td>612562</td></tr><tr><td></td><td>
<italic>RPL35A</italic>
</td><td>DIAMOND-BLACKFAN ANEMIA 5</td><td>612528</td></tr><tr><td></td><td>
<italic>RPS23</italic>
</td><td>BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY</td><td>617412</td></tr><tr><td></td><td>
<italic>RPL5</italic>
</td><td>DIAMOND-BLACKFAN ANEMIA 6</td><td>612561</td></tr><tr><td colspan="4"> Chaperonin-mediated protein folding</td></tr><tr><td></td><td>
<italic>CCT5</italic>
</td><td>NEUROPATHY, HEREDITARY SENSORY, WITH SPASTIC PARAPLEGIA</td><td>256840</td></tr><tr><td></td><td>
<italic>CSNK2A1</italic>
</td><td>OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME</td><td>617062</td></tr><tr><td></td><td>
<italic>GNAI2</italic>
</td><td>VENTRICULAR TACHYCARDIA, FAMILIAL</td><td>192605</td></tr><tr><td></td><td>
<italic>GNAI3</italic>
</td><td>AURICULOCONDYLAR SYNDROME 1</td><td>602483</td></tr><tr><td></td><td>
<italic>GNAO1</italic>
</td><td>NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS</td><td>617493</td></tr><tr><td></td><td>
<italic>GNAO1</italic>
</td><td>EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17</td><td>615473</td></tr><tr><td></td><td>
<italic>GNB3</italic>
</td><td>NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1H</td><td>617024</td></tr><tr><td></td><td>
<italic>GNB4</italic>
</td><td>CHARCOT-MARIE-TOOTH DISEASE</td><td>615185</td></tr><tr><td></td><td>
<italic>GNB5</italic>
</td><td>LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER</td><td>617182</td></tr><tr><td></td><td>
<italic>RGS9</italic>
</td><td>PROLONGED ELECTRORETINAL RESPONSE SUPPRESSION</td><td>608415</td></tr><tr><td colspan="4"> Different proteasome pathways</td></tr><tr><td></td><td>
<italic>APC</italic>
</td><td>FAMILIAL ADENOMATOUS POLYPOSIS 1</td><td>175100</td></tr><tr><td></td><td>
<italic>CTNNB1</italic>
</td><td>MENTAL RETARDATION, AUTOSOMAL DOMINANT 19</td><td>615075</td></tr><tr><td></td><td>
<italic>PPP2R1A</italic>
</td><td>MENTAL RETARDATION, AUTOSOMAL DOMINANT 36</td><td>616362</td></tr><tr><td colspan="4">Endocytosis and traffic of neurotransmitter receptors</td></tr><tr><td colspan="4"> Trafficking of AMPA receptors</td></tr><tr><td></td><td><italic>AP2S1</italic> (2)</td><td>HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III</td><td>600740</td></tr><tr><td></td><td>
<italic>CACNG2</italic>
</td><td>MENTAL RETARDATION, AUTOSOMAL DOMINANT 10</td><td>614256</td></tr><tr><td></td><td>
<italic>CAMK2A</italic>
</td><td>MENTAL RETARDATION, AUTOSOMAL DOMINANT 53</td><td>617798</td></tr><tr><td></td><td>
<italic>CAMK2B</italic>
</td><td>MENTAL RETARDATION, AUTOSOMAL DOMINANT 54</td><td>617799</td></tr><tr><td></td><td>
<italic>EPB4.1 L1</italic>
</td><td>MENTAL RETARDATION, AUTOSOMAL DOMINANT 11</td><td>614257</td></tr><tr><td></td><td>
<italic>GRIA3</italic>
</td><td>MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE</td><td>300699</td></tr><tr><td></td><td>
<italic>GRIA4</italic>
</td><td>NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES</td><td>617864</td></tr><tr><td></td><td>
<italic>GRIP1</italic>
</td><td>FRASER SYNDROME 3</td><td>617667</td></tr><tr><td></td><td>
<italic>MYO6</italic>
</td><td>DEAFNESS, AUTOSOMAL DOMINANT 22</td><td>606346</td></tr><tr><td></td><td>
<italic>PRKCG</italic>
</td><td>RETINITIS PIGMENTOSA 11</td><td>600138</td></tr><tr><td></td><td>
<italic>PRKCG</italic>
</td><td>SPINOCEREBELLAR ATAXIA 14</td><td>605361</td></tr><tr><td colspan="4"> Clathrin-mediated endocytosis</td></tr><tr><td></td><td><italic>ACTB</italic> (3)</td><td>BARAITSER-WINTER SYNDROME 1</td><td>243310</td></tr><tr><td></td><td><italic>ACTG1</italic> (3)</td><td>BARAITSER-WINTER SYNDROME 2</td><td>614583</td></tr><tr><td></td><td>
<italic>DNM2</italic>
</td><td>CHARCOT-MARIE-TOOTH DISEASE</td><td>606482</td></tr><tr><td></td><td>
<italic>NECAP1</italic>
</td><td>EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21</td><td>615833</td></tr><tr><td></td><td>
<italic>PIP5K1C</italic>
</td><td>LETHAL CONGENITAL CONTRACTURE SYNDROME 3</td><td>611369</td></tr><tr><td></td><td>
<italic>WNT5A</italic>
</td><td>ROBINOW SYNDROME, AUTOSOMAL DOMINANT 1</td><td>189700</td></tr></tbody></table><table-wrap-foot><p>(1) This gene causes six different syndromes with similar phenotypes, none of which are of a clear neurological nature</p><p>(2) AP2S1 is also in the group of proteins implicated in ‘Clathrin-mediated endocytosis’</p><p>(3) ACTB and ACTG1 are also in the group of proteins implicated in ‘Translocation of GLUT4 to the plasma membrane’</p></table-wrap-foot></table-wrap></p>
</sec>
<sec id="Sec8">
<title>Most inherited diseases caused by metabolism proteins in the PSD show neurological symptoms</title>
<p id="Par13">The phenotypic information obtained from HPO allowed us to identify those clinical conditions from OMIM that present neurological manifestations. Interestingly, of all 60 disorders, only eight did not cause neurological symptoms (Supplementary Table <xref ref-type="media" rid="MOESM2">2</xref> and Table <xref ref-type="table" rid="Tab3">3</xref>). This indicates that the majority of these proteins perform important functions in the brain and may be also at the postsynaptic level. The list of identified disorders includes (i) eight forms of intellectual disabilities, (ii) three epileptic encephalopathies, (iii) three neurodevelopmental conditions, (iv) three types of cortical dysplasia and (v) one lissencephaly, as well as neuropathies such as Charcot-Marie-Tooth diseases (Supplementary Table <xref ref-type="media" rid="MOESM2">2</xref>). When looking at disease types caused by proteins involved in the same metabolic pathways, we see that (i) large brain malformations such as cortical dysplasias and lissencephaly are caused by proteins—mostly tubulins—involved in the pathway ‘Translocation of GLUT4 to the plasma membrane’ and (ii) intellectual disabilities are very common among proteins involved in ‘Trafficking of AMPA receptors’, which is likely the pathway most specific to postsynaptic function. Finally, I have identified many anemias caused by proteins involved in protein translation, although these present few neurological symptoms, besides migraine (see Supplementary Table <xref ref-type="media" rid="MOESM2">2</xref>).<table-wrap id="Tab3"><label>Table 3</label><caption><p>Number of diseases presenting major neurological symptoms</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Pathway</th><th>Intellectual disability</th><th>Seizures</th><th>Microcephaly</th><th>Generalised hypotonia</th><th>Migraine</th><th>Specific learning disability</th><th>Hypoplasia of the corpus callosum</th><th>Hyporeflexia</th><th>Spasticity</th></tr></thead><tbody><tr><td colspan="10">Energetic metabolism</td></tr><tr><td> Glycolysis (including glucose transporters)</td><td>2</td><td>2</td><td>1</td><td>1</td><td>0</td><td>1</td><td>0</td><td>2</td><td>3</td></tr><tr><td> Translocation of GLUT4 to the plasma membrane</td><td>2</td><td>7</td><td>3</td><td>2</td><td>0</td><td>2</td><td>4</td><td>1</td><td>2</td></tr><tr><td colspan="10">Protein metabolism</td></tr><tr><td> Protein translation</td><td>1</td><td>0</td><td>2</td><td>1</td><td>9</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td> Chaperonin-mediated protein folding</td><td>2</td><td>1</td><td>1</td><td>2</td><td>0</td><td>0</td><td>1</td><td>1</td><td>0</td></tr><tr><td> Different proteasome pathways</td><td>2</td><td>3</td><td>3</td><td>3</td><td>0</td><td>0</td><td>2</td><td>0</td><td>0</td></tr><tr><td colspan="10">Endocytosis and traffic of neurotransmitter receptors</td></tr><tr><td> Trafficking of AMPA receptors</td><td>6</td><td>1</td><td>1</td><td>0</td><td>0</td><td>0</td><td>0</td><td>1</td><td>0</td></tr><tr><td> Clathrin-mediated endocytosis</td><td>3</td><td>3</td><td>2</td><td>3</td><td>0</td><td>3</td><td>0</td><td>1</td><td>0</td></tr><tr><td>Total</td><td>18</td><td>17</td><td>13</td><td>12</td><td>9</td><td>6</td><td>7</td><td>6</td><td>5</td></tr></tbody></table></table-wrap></p>
</sec>
<sec id="Sec9">
<title>Intellectual disability and seizures are among the most common symptoms caused by metabolism proteins in the PSD</title>
<p id="Par14">We first looked into the overall number of different phenotypes caused by these 60 diseases. Surprisingly, 836 different phenotypes were identified, indicating the complex nature of the conditions caused by these 53 proteins. This is further illustrated by the fact that most phenotypes are only found in one or two disorders (691/836, ≈ 83% of the total). Among the most frequent symptoms identified by HPO (Table <xref ref-type="table" rid="Tab3">3</xref>), two are neurological: ‘Intellectual Disability’ (in 18 different diseases) and ‘Seizures’ (in 17). Other relevant neurological symptoms identified are ‘Microcephaly’, ‘Specific Learning Disabilities’, ‘Hyporeflexia’ or ‘Spasticity’. Some of these symptoms were much more commonly found in conditions caused by proteins from the same metabolic pathway. The most extreme case is that of ‘Spasticity’, which is only caused by proteins related to energetic metabolism. Another example is found in ‘Specific Learning Disabilities’ that is absent from diseases caused by the protein machinery involved in protein metabolism. Many of these diseases are related to the new categories of inborn errors of metabolism affecting systems involved in intracellular vesiculation, trafficking, processing of complex molecules and quality control processes (such as protein folding and autophagy) (García-Cazorla and Saudubray, this issue).</p>
<p id="Par15">The elevated frequency of intellectual disability and seizures among disorders caused by proteins related to postsynaptic metabolic pathways is in favour of a postsynaptic role in some of these conditions. These two phenotypes are characteristic of disorders caused by genes coding for proteins with a very prominent role at the PSD. This is the case of ionotropic glutamate receptors and their auxiliary proteins (Soto et al. <xref ref-type="bibr" rid="CR63">2014</xref>; Bayés et al. <xref ref-type="bibr" rid="CR7">2014</xref>; Volk et al. <xref ref-type="bibr" rid="CR67">2015</xref>; Zehavi et al. <xref ref-type="bibr" rid="CR71">2017</xref>), <italic>SYNGAP1</italic> (Hamdan et al. <xref ref-type="bibr" rid="CR31">2009</xref>; Clement et al. <xref ref-type="bibr" rid="CR16">2012</xref>), <italic>DLG3</italic> (Tarpey et al. <xref ref-type="bibr" rid="CR66">2004</xref>), <italic>SHANK2</italic> (Berkel et al. <xref ref-type="bibr" rid="CR10">2010</xref>; Leblond et al. <xref ref-type="bibr" rid="CR41">2012</xref>), <italic>SHANK3</italic> (Guilmatre et al. <xref ref-type="bibr" rid="CR30">2014</xref>), <italic>NEUROLIGIN 2</italic> (Parente et al. <xref ref-type="bibr" rid="CR51">2017</xref>) or <italic>OPHN1</italic> (Billuart et al. <xref ref-type="bibr" rid="CR11">1998</xref>), to mention just a few. These phenotypic correspondences would support the notion that postsynaptic dysfunction might have a role in some neurometabolic disorders. Nevertheless, further research in this field must be done to corroborate this hypothesis.</p>
</sec>
</sec>
<sec id="Sec10">
<title>Conclusions</title>
<p id="Par16">In the recently developed field of synaptopathies (Brose et al. <xref ref-type="bibr" rid="CR14">2010</xref>; Grant <xref ref-type="bibr" rid="CR27">2012</xref>), the role of many postsynaptic proteins in mental disorders is already well established (Guilmatre et al. <xref ref-type="bibr" rid="CR29">2009</xref>; Hamdan et al. <xref ref-type="bibr" rid="CR32">2011</xref>; Kirov et al. <xref ref-type="bibr" rid="CR39">2011</xref>). Nevertheless, the vast majority of postsynaptic proteins known to cause brain conditions are not involved in metabolism. In this article, I have explored the possibility of a primary role in disease of postsynaptic proteins involved in metabolic pathways. I have shown that energy production, protein turnover and neurotransmitter receptor traffic are the major metabolic pathways present at the postsynapse and that many proteins from these processes cause inherited disorders encompassing neurological manifestations. Importantly, the most common neurological phenotypes caused by these disorders are intellectual disability and seizures. Although, many other symptoms are present, including movement disorders, as recently reported (Kurian M, this issue). The fact that intellectual disability and seizures are key phenotypes of well-established synaptopathies caused by postsynaptic proteins and of conditions caused by postsynaptic proteins involved in metabolism is suggestive of a role of postsynaptic metabolism in certain neurological conditions. Future research will be required to explore this hypothesis.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Electronic supplementary material</title>
<sec id="Sec11">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="10545_2018_240_MOESM1_ESM.xlsx"><label>Supplementary Table 1</label><caption><p>(XLSX 33 kb)</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="10545_2018_240_MOESM2_ESM.xlsx"><label>Supplementary Table 2</label><caption><p>(XLSX 18 kb)</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<ack>
<p>AB wishes to thank Dr. Angels García-Cazorla (Hospital Sant Joan de Déu, Barcelona, Spain) for fruitful discussions on the subject of this article.</p>
</ack>
<notes notes-type="funding-information">
<title>Funding information</title>
<p>Financial support was from Spanish grants ref. BFU2012-34398, BFU2015-69717-P (partially funded by FEDER funds of the EU), Ramón y Cajal Fellowship, ref. RYC-2011-08391 and from the European FP People: Marie Curie Action: Career Integration Grant, ref. 304111. Support was also obtained from the CERCA Programme/Generalitat de Catalunya.</p>
</notes>
<notes notes-type="COI-statement">
<sec id="FPar1">
<title>Conflict of interest</title>
<p>Àlex Bayés declares that he has no conflict of interest.</p>
</sec>
<sec id="FPar2">
<title>Animal rights</title>
<p>This article does not contain any studies with human or animal subjects performed by any of the authors.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<mixed-citation publication-type="other">Anggono V, Huganir RL (2012) Regulation of AMPA receptor trafficking and synaptic plasticity. Curr Opin Neurobiol. 10.1016/j.conb.2011.12.006</mixed-citation>
</ref>
<ref id="CR2">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ashrafi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Farrell</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Ryan</surname>
<given-names>TA</given-names>
</name>
</person-group>
<article-title>GLUT4 mobilization supports energetic demands of active synapses</article-title>
<source/>Neuron
          <year>2017</year>
<volume>93</volume>
<fpage>606</fpage>
<lpage>615.e3</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2016.12.020</pub-id>
<pub-id pub-id-type="pmid">28111082</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Attwell</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Laughlin</surname>
<given-names>SB</given-names>
</name>
</person-group>
<article-title>An energy budget for signaling in the grey matter of the brain</article-title>
<source/>J Cereb Blood Flow Metab
          <year>2001</year>
<volume>21</volume>
<fpage>1133</fpage>
<lpage>1145</lpage>
<pub-id pub-id-type="doi">10.1097/00004647-200110000-00001</pub-id>
<pub-id pub-id-type="pmid">11598490</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bayés</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Grant</surname>
<given-names>SGN</given-names>
</name>
</person-group>
<article-title>Neuroproteomics: understanding the molecular organization and complexity of the brain</article-title>
<source/>Nat Rev Neurosci
          <year>2009</year>
<volume>10</volume>
<fpage>635</fpage>
<lpage>646</lpage>
<pub-id pub-id-type="doi">10.1038/nrn2701</pub-id>
<pub-id pub-id-type="pmid">19693028</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bayés</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Van De Lagemaat</surname>
<given-names>LN</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>MO</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Characterization of the proteome, diseases and evolution of the human postsynaptic density</article-title>
<source/>Nat Neurosci
          <year>2011</year>
<volume>14</volume>
<fpage>19</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="doi">10.1038/nn.2719</pub-id>
<pub-id pub-id-type="pmid">21170055</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bayés</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>MO</given-names>
</name>
<name>
<surname>Croning</surname>
<given-names>MDR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Comparative study of human and mouse postsynaptic proteomes finds high compositional conservation and abundance differences for key synaptic proteins</article-title>
<source/>PLoS One
          <year>2012</year>
<volume>7</volume>
<fpage>e46683</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0046683</pub-id>
<pub-id pub-id-type="pmid">23071613</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bayés</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>MO</given-names>
</name>
<name>
<surname>Galtrey</surname>
<given-names>CM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human post-mortem synapse proteome integrity screening for proteomic studies of postsynaptic complexes</article-title>
<source/>Mol Brain
          <year>2014</year>
<volume>7</volume>
<fpage>635</fpage>
<pub-id pub-id-type="doi">10.1186/s13041-014-0088-4</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bayés</surname>
<given-names>À</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>MO</given-names>
</name>
<name>
<surname>Reig-Viader</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Evolution of complexity in the zebrafish synapse proteome</article-title>
<source/>Nat Commun
          <year>2017</year>
<volume>8</volume>
<fpage>1</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="doi">10.1038/ncomms14613</pub-id>
<pub-id pub-id-type="pmid">28232747</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beaulieu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Colonnier</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>A laminar analysis of the number of round-asymmetrical and flat-symmetrical synapses on spines, dendritic trunks, and cell bodies in area 17 of the cat</article-title>
<source/>J Comp Neurol
          <year>1985</year>
<volume>231</volume>
<fpage>180</fpage>
<lpage>189</lpage>
<pub-id pub-id-type="doi">10.1002/cne.902310206</pub-id>
<pub-id pub-id-type="pmid">3968234</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berkel</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Weiss</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation</article-title>
<source/>Nat Genet
          <year>2010</year>
<volume>42</volume>
<fpage>489</fpage>
<lpage>491</lpage>
<pub-id pub-id-type="doi">10.1038/ng.589</pub-id>
<pub-id pub-id-type="pmid">20473310</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Billuart</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Bienvenu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ronce</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Oligophrenin-1 encodes a rhoGAP protein involved in X-linked mental retardation</article-title>
<source/>Nature
          <year>1998</year>
<volume>392</volume>
<fpage>923</fpage>
<lpage>926</lpage>
<pub-id pub-id-type="doi">10.1038/31940</pub-id>
<pub-id pub-id-type="pmid">9582072</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bingol</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Schuman</surname>
<given-names>EM</given-names>
</name>
</person-group>
<article-title>Activity-dependent dynamics and sequestration of proteasomes in dendritic spines</article-title>
<source/>Nature
          <year>2006</year>
<volume>441</volume>
<fpage>1144</fpage>
<lpage>1148</lpage>
<pub-id pub-id-type="doi">10.1038/nature04769</pub-id>
<pub-id pub-id-type="pmid">16810255</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boeckers</surname>
<given-names>TM</given-names>
</name>
</person-group>
<article-title>The postsynaptic density</article-title>
<source/>Cell Tissue Res
          <year>2006</year>
<volume>326</volume>
<fpage>409</fpage>
<lpage>422</lpage>
<pub-id pub-id-type="doi">10.1007/s00441-006-0274-5</pub-id>
<pub-id pub-id-type="pmid">16865346</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brose</surname>
<given-names>N</given-names>
</name>
<name>
<surname>O’Connor</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Skehel</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Synaptopathy: dysfunction of synaptic function?</article-title>
<source/>Biochem Soc Trans
          <year>2010</year>
<volume>38</volume>
<fpage>443</fpage>
<lpage>444</lpage>
<pub-id pub-id-type="doi">10.1042/BST0380443</pub-id>
<pub-id pub-id-type="pmid">20298199</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carlin</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Grab</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Siekevitz</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Isolation and characterization of postsynaptic densities from various brain regions: enrichment of different types of postsynaptic densities</article-title>
<source/>J Cell Biol
          <year>1980</year>
<volume>86</volume>
<fpage>831</fpage>
<lpage>845</lpage>
<pub-id pub-id-type="doi">10.1083/jcb.86.3.831</pub-id>
<pub-id pub-id-type="pmid">7410481</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clement</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Aceti</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Creson</surname>
<given-names>TK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pathogenic SYNGAP1 mutations impair cognitive development by disrupting maturation of dendritic spine synapses</article-title>
<source/>Cell
          <year>2012</year>
<volume>151</volume>
<fpage>709</fpage>
<lpage>723</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2012.08.045</pub-id>
<pub-id pub-id-type="pmid">23141534</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cortès-Saladelafont</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Tristán-Noguero</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Artuch</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Diseases of the synaptic vesicle: a potential new group of neurometabolic disorders affecting neurotransmission</article-title>
<source/>Semin Pediatr Neurol
          <year>2016</year>
<volume>23</volume>
<fpage>306</fpage>
<lpage>320</lpage>
<pub-id pub-id-type="doi">10.1016/j.spen.2016.11.005</pub-id>
<pub-id pub-id-type="pmid">28284392</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Robertis</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>HS</given-names>
</name>
</person-group>
<article-title>Submicroscopic vesicular component in the synapse</article-title>
<source/>Fed Proc
          <year>1954</year>
<volume>13</volume>
<fpage>35</fpage>
<lpage>42</lpage>
</element-citation>
</ref>
<ref id="CR19">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Defelipe</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Alonso-Nanclares</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Arellano</surname>
<given-names>JI</given-names>
</name>
</person-group>
<article-title>Microstructure of the neocortex: comparative aspects</article-title>
<source/>J Neurocytol
          <year>2002</year>
<volume>31</volume>
<fpage>299</fpage>
<lpage>316</lpage>
<pub-id pub-id-type="doi">10.1023/A:1024130211265</pub-id>
<pub-id pub-id-type="pmid">12815249</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Distler</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Schmeisser</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Pelosi</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>In-depth protein profiling of the postsynaptic density from mouse hippocampus using data-independent acquisition proteomics</article-title>
<source/>Proteomics
          <year>2014</year>
<volume>14</volume>
<fpage>2607</fpage>
<lpage>2613</lpage>
<pub-id pub-id-type="doi">10.1002/pmic.201300520</pub-id>
<pub-id pub-id-type="pmid">25211037</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dosemeci</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Weinberg</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Reese</surname>
<given-names>TS</given-names>
</name>
<name>
<surname>Tao-Cheng</surname>
<given-names>J-H</given-names>
</name>
</person-group>
<article-title>The postsynaptic density: there is more than meets the eye</article-title>
<source/>Front Synaptic Neurosci
          <year>2016</year>
<volume>8</volume>
<fpage>23</fpage>
<pub-id pub-id-type="doi">10.3389/fnsyn.2016.00023</pub-id>
<pub-id pub-id-type="pmid">27594834</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ehlers</surname>
<given-names>MD</given-names>
</name>
</person-group>
<article-title>Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system</article-title>
<source/>Nat Neurosci
          <year>2003</year>
<volume>6</volume>
<fpage>231</fpage>
<lpage>242</lpage>
<pub-id pub-id-type="doi">10.1038/nn1013</pub-id>
<pub-id pub-id-type="pmid">12577062</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fabregat</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jupe</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Matthews</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Reactome Pathway Knowledgebase</article-title>
<source/>Nucleic Acids Res
          <year>2018</year>
<volume>46</volume>
<fpage>D649</fpage>
<lpage>D655</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkx1132</pub-id>
<pub-id pub-id-type="pmid">29145629</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernandez</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>MO</given-names>
</name>
<name>
<surname>Uren</surname>
<given-names>RT</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Targeted tandem affinity purification of PSD-95 recovers core postsynaptic complexes and schizophrenia susceptibility proteins</article-title>
<source/>Mol Syst Biol
          <year>2009</year>
<volume>5</volume>
<fpage>269</fpage>
<pub-id pub-id-type="doi">10.1038/msb.2009.27</pub-id>
<pub-id pub-id-type="pmid">19455133</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferreira</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Burnett</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Rameau</surname>
<given-names>GA</given-names>
</name>
</person-group>
<article-title>Activity-dependent regulation of surface glucose transporter-3</article-title>
<source/>J Neurosci
          <year>2011</year>
<volume>31</volume>
<fpage>1991</fpage>
<lpage>1999</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1850-09.2011</pub-id>
<pub-id pub-id-type="pmid">21307237</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Focking</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Dicker</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lopez</surname>
<given-names>LM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Proteomic analysis of the postsynaptic density implicates synaptic function and energy pathways in bipolar disorder</article-title>
<source/>Transl Psychiatry
          <year>2016</year>
<volume>6</volume>
<fpage>e959</fpage>
<lpage>e959</lpage>
<pub-id pub-id-type="doi">10.1038/tp.2016.224</pub-id>
<pub-id pub-id-type="pmid">27898073</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grant</surname>
<given-names>SG</given-names>
</name>
</person-group>
<article-title>Synaptopathies: diseases of the synaptome</article-title>
<source/>Curr Opin Neurobiol
          <year>2012</year>
<volume>22</volume>
<fpage>522</fpage>
<lpage>529</lpage>
<pub-id pub-id-type="doi">10.1016/j.conb.2012.02.002</pub-id>
<pub-id pub-id-type="pmid">22409856</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gray</surname>
<given-names>EG</given-names>
</name>
</person-group>
<article-title>Electron microscopy of synaptic contacts on dendrite spines of the cerebral cortex</article-title>
<source/>Nature
          <year>1959</year>
<volume>183</volume>
<fpage>1592</fpage>
<lpage>1593</lpage>
<pub-id pub-id-type="doi">10.1038/1831592a0</pub-id>
<pub-id pub-id-type="pmid">13666826</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guilmatre</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dubourg</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mosca</surname>
<given-names>AL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation</article-title>
<source/>Arch Gen Psychiatry
          <year>2009</year>
<volume>66</volume>
<fpage>947</fpage>
<lpage>956</lpage>
<pub-id pub-id-type="doi">10.1001/archgenpsychiatry.2009.80</pub-id>
<pub-id pub-id-type="pmid">19736351</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guilmatre</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Huguet</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Delorme</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bourgeron</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>The emerging role of SHANK genes in neuropsychiatric disorders</article-title>
<source/>Dev Neurobiol
          <year>2014</year>
<volume>74</volume>
<fpage>113</fpage>
<lpage>122</lpage>
<pub-id pub-id-type="doi">10.1002/dneu.22128</pub-id>
<pub-id pub-id-type="pmid">24124131</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hamdan</surname>
<given-names>FF</given-names>
</name>
<name>
<surname>Gauthier</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Spiegelman</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation</article-title>
<source/>N Engl J Med
          <year>2009</year>
<volume>360</volume>
<fpage>599</fpage>
<lpage>605</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa0805392</pub-id>
<pub-id pub-id-type="pmid">19196676</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hamdan</surname>
<given-names>FF</given-names>
</name>
<name>
<surname>Gauthier</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Araki</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability</article-title>
<source/>Am J Hum Genet
          <year>2011</year>
<volume>88</volume>
<fpage>306</fpage>
<lpage>316</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2011.02.001</pub-id>
<pub-id pub-id-type="pmid">21376300</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harris</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Jolivet</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Attwell</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Synaptic energy use and supply</article-title>
<source/>Neuron
          <year>2012</year>
<volume>75</volume>
<fpage>762</fpage>
<lpage>777</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2012.08.019</pub-id>
<pub-id pub-id-type="pmid">22958818</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Hoffman</surname>
<given-names>GF</given-names>
</name>
<name>
<surname>Blau</surname>
<given-names>N</given-names>
</name>
</person-group>
<source/>Congenital neurotransmitter disorders: a clinical approach
          <year>2014</year>
<edition>1</edition>
<publisher-loc>New York</publisher-loc>
<publisher-name>Nova Science Publishers Inc.</publisher-name>
</element-citation>
</ref>
<ref id="CR35">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ikemoto</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bole</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Ueda</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Glycolysis and glutamate accumulation into synaptic vesicles</article-title>
<source/>J Biol Chem
          <year>2003</year>
<volume>278</volume>
<fpage>5929</fpage>
<lpage>5940</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M211617200</pub-id>
<pub-id pub-id-type="pmid">12488440</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Bend</surname>
<given-names>EG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Glycolytic enzymes localize to synapses under energy stress to support synaptic function</article-title>
<source/>Neuron
          <year>2016</year>
<volume>90</volume>
<fpage>278</fpage>
<lpage>291</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2016.03.011</pub-id>
<pub-id pub-id-type="pmid">27068791</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jurcovicova</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Glucose transport in brain - effect of inflammation</article-title>
<source/>Endocr Regul
          <year>2014</year>
<volume>48</volume>
<fpage>35</fpage>
<lpage>48</lpage>
<pub-id pub-id-type="doi">10.4149/endo_2014_01_35</pub-id>
<pub-id pub-id-type="pmid">24524374</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sheng</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The postsynaptic density</article-title>
<source/>Curr Biol
          <year>2009</year>
<volume>19</volume>
<fpage>R723</fpage>
<lpage>R724</lpage>
<pub-id pub-id-type="doi">10.1016/j.cub.2009.07.047</pub-id>
<pub-id pub-id-type="pmid">19906568</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kirov</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Pocklington</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Holmans</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia</article-title>
<source/>Mol Psychiatry
          <year>2011</year>
<volume>17</volume>
<fpage>142</fpage>
<lpage>153</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2011.154</pub-id>
<pub-id pub-id-type="pmid">22083728</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Köhler</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Vasilevsky</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Engelstad</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The human phenotype ontology in 2017</article-title>
<source/>Nucleic Acids Res
          <year>2017</year>
<volume>45</volume>
<fpage>D865</fpage>
<lpage>D876</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkw1039</pub-id>
<pub-id pub-id-type="pmid">27899602</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leblond</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Heinrich</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Delorme</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders</article-title>
<source/>PLoS Genet
          <year>2012</year>
<volume>8</volume>
<fpage>e1002521</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1002521</pub-id>
<pub-id pub-id-type="pmid">22346768</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leino</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Gerhart</surname>
<given-names>DZ</given-names>
</name>
<name>
<surname>van Bueren</surname>
<given-names>AM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Ultrastructural localization of GLUT 1 and GLUT 3 glucose transporters in rat brain</article-title>
<source/>J Neurosci Res
          <year>1997</year>
<volume>49</volume>
<fpage>617</fpage>
<lpage>626</lpage>
<pub-id pub-id-type="doi">10.1002/(SICI)1097-4547(19970901)49:5&lt;617::AID-JNR12&gt;3.0.CO;2-S</pub-id>
<pub-id pub-id-type="pmid">9302083</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Okamoto</surname>
<given-names>K-I</given-names>
</name>
<name>
<surname>Hayashi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sheng</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses</article-title>
<source/>Cell
          <year>2004</year>
<volume>119</volume>
<fpage>873</fpage>
<lpage>887</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2004.11.003</pub-id>
<pub-id pub-id-type="pmid">15607982</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marecos</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kurian</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>What is new for monoamine neurotransmitter disorders?</article-title>
<source/>J Inherit Metab Dis
          <year>2014</year>
<volume>37</volume>
<fpage>619</fpage>
<lpage>626</lpage>
<pub-id pub-id-type="doi">10.1007/s10545-014-9697-4</pub-id>
<pub-id pub-id-type="pmid">24696406</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Barad</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kandel</surname>
<given-names>ER</given-names>
</name>
</person-group>
<article-title>Local protein synthesis and its role in synapse-specific plasticity</article-title>
<source/>Curr Opin Neurobiol
          <year>2000</year>
<volume>10</volume>
<fpage>587</fpage>
<lpage>592</lpage>
<pub-id pub-id-type="doi">10.1016/S0959-4388(00)00128-8</pub-id>
<pub-id pub-id-type="pmid">11084321</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McKusick</surname>
<given-names>VA</given-names>
</name>
</person-group>
<article-title>Mendelian inheritance in man and its online version, OMIM</article-title>
<source/>Am J Hum Genet
          <year>2007</year>
<volume>80</volume>
<fpage>588</fpage>
<lpage>604</lpage>
<pub-id pub-id-type="doi">10.1086/514346</pub-id>
<pub-id pub-id-type="pmid">17357067</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Poudel</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Muruganujan</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>PANTHER version 10: expanded protein families and functions, and analysis tools</article-title>
<source/>Nucleic Acids Res
          <year>2016</year>
<volume>44</volume>
<fpage>D336</fpage>
<lpage>D342</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkv1194</pub-id>
<pub-id pub-id-type="pmid">26578592</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Papandreou</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Heales</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Kurian</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Monoamine neurotransmitter disorders-clinical advances and future perspectives</article-title>
<source/>Nat Rev Neurol
          <year>2015</year>
<volume>11</volume>
<fpage>567</fpage>
<lpage>584</lpage>
<pub-id pub-id-type="doi">10.1038/nrneurol.2015.172</pub-id>
<pub-id pub-id-type="pmid">26392380</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ostroff</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Fiala</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Allwardt</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>KM</given-names>
</name>
</person-group>
<article-title>Polyribosomes redistribute from dendritic shafts into spines with enlarged synapses during LTP in developing rat hippocampal slices</article-title>
<source/>Neuron
          <year>2002</year>
<volume>35</volume>
<fpage>535</fpage>
<lpage>545</lpage>
<pub-id pub-id-type="doi">10.1016/S0896-6273(02)00785-7</pub-id>
<pub-id pub-id-type="pmid">12165474</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palade</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Palay</surname>
<given-names>SL</given-names>
</name>
</person-group>
<article-title>Electron microscope observations of interneuronal and neuromuscular synapses</article-title>
<source/>Anat Rec
          <year>1954</year>
<volume>118</volume>
<fpage>335</fpage>
<lpage>336</lpage>
</element-citation>
</ref>
<ref id="CR51">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parente</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Garriga</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Baskin</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neuroligin 2 nonsense variant associated with anxiety, autism, intellectual disability, hyperphagia, and obesity</article-title>
<source/>Am J Med Genet A
          <year>2017</year>
<volume>173</volume>
<fpage>213</fpage>
<lpage>216</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.37977</pub-id>
<pub-id pub-id-type="pmid">27865048</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pearl</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Trzcinski</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sokohl</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The pediatric neurotransmitter disorders</article-title>
<source/>J Child Neurol
          <year>2007</year>
<volume>22</volume>
<fpage>606</fpage>
<lpage>616</lpage>
<pub-id pub-id-type="doi">10.1177/0883073807302619</pub-id>
<pub-id pub-id-type="pmid">17690069</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pearl</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Quezado</surname>
<given-names>Z</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Decreased GABA-A binding on FMZ-PET in succinic semialdehyde dehydrogenase deficiency</article-title>
<source/>Neurology
          <year>2009</year>
<volume>73</volume>
<fpage>423</fpage>
<lpage>429</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.0b013e3181b163a5</pub-id>
<pub-id pub-id-type="pmid">19667317</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Racz</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Blanpied</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Ehlers</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Weinberg</surname>
<given-names>RJ</given-names>
</name>
</person-group>
<article-title>Lateral organization of endocytic machinery in dendritic spines</article-title>
<source/>Nat Neurosci
          <year>2004</year>
<volume>7</volume>
<fpage>917</fpage>
<lpage>918</lpage>
<pub-id pub-id-type="doi">10.1038/nn1303</pub-id>
<pub-id pub-id-type="pmid">15322548</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rangaraju</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Calloway</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ryan</surname>
<given-names>TA</given-names>
</name>
</person-group>
<article-title>Activity-driven local ATP synthesis is required for synaptic function</article-title>
<source/>Cell
          <year>2014</year>
<volume>156</volume>
<fpage>825</fpage>
<lpage>835</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2013.12.042</pub-id>
<pub-id pub-id-type="pmid">24529383</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reig-Viader</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sindreu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bayés</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Synaptic proteomics as a means to identify the molecular basis of mental illness: are we getting there?</article-title>
<source/>Prog Neuro-Psychopharmacol Biol Psychiatry
          <year>2018</year>
<volume>84</volume>
<fpage>353</fpage>
<lpage>361</lpage>
<pub-id pub-id-type="doi">10.1016/j.pnpbp.2017.09.011</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reis</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Pearl</surname>
<given-names>PL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>GABAB-ergic motor cortex dysfunction in SSADH deficiency</article-title>
<source/>Neurology
          <year>2012</year>
<volume>79</volume>
<fpage>47</fpage>
<lpage>54</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.0b013e31825dcf71</pub-id>
<pub-id pub-id-type="pmid">22722631</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roy</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sorokina</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Skene</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Proteomic analysis of postsynaptic proteins in regions of the human neocortex</article-title>
<source/>Nat Neurosci
          <year>2018</year>
<volume>21</volume>
<fpage>130</fpage>
<lpage>138</lpage>
<pub-id pub-id-type="doi">10.1038/s41593-017-0025-9</pub-id>
<pub-id pub-id-type="pmid">29203896</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salomons</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>van Dooren</surname>
<given-names>SJM</given-names>
</name>
<name>
<surname>Verhoeven</surname>
<given-names>NM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>X-linked creatine transporter defect: an overview</article-title>
<source/>J Inherit Metab Dis
          <year>2003</year>
<volume>26</volume>
<fpage>309</fpage>
<lpage>318</lpage>
<pub-id pub-id-type="doi">10.1023/A:1024405821638</pub-id>
<pub-id pub-id-type="pmid">12889669</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sheng</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>The postsynaptic organization of synapses</article-title>
<source/>Cold Spring Harb Perspect Biol
          <year>2011</year>
<volume>3</volume>
<fpage>a005678</fpage>
<lpage>a005678</lpage>
<pub-id pub-id-type="doi">10.1101/cshperspect.a005678</pub-id>
<pub-id pub-id-type="pmid">22046028</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shepherd</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Huganir</surname>
<given-names>RL</given-names>
</name>
</person-group>
<article-title>The cell biology of synaptic plasticity: AMPA receptor trafficking</article-title>
<source/>Annu Rev Cell Dev Biol
          <year>2007</year>
<volume>23</volume>
<fpage>613</fpage>
<lpage>643</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.cellbio.23.090506.123516</pub-id>
<pub-id pub-id-type="pmid">17506699</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simpson</surname>
<given-names>IA</given-names>
</name>
<name>
<surname>Carruthers</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vannucci</surname>
<given-names>SJ</given-names>
</name>
</person-group>
<article-title>Supply and demand in cerebral energy metabolism: the role of nutrient transporters</article-title>
<source/>J Cereb Blood Flow Metab
          <year>2007</year>
<volume>27</volume>
<fpage>1766</fpage>
<lpage>1791</lpage>
<pub-id pub-id-type="doi">10.1038/sj.jcbfm.9600521</pub-id>
<pub-id pub-id-type="pmid">17579656</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soto</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Altafaj</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Sindreu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bayés</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Glutamate receptor mutations in psychiatric and neurodevelopmental disorders</article-title>
<source/>Commun Integr Biol
          <year>2014</year>
<volume>7</volume>
<fpage>e27887</fpage>
<pub-id pub-id-type="doi">10.4161/cib.27887</pub-id>
<pub-id pub-id-type="pmid">24605182</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spacek</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Three-dimensional analysis of dendritic spines. II. Spine apparatus and other cytoplasmic components</article-title>
<source/>Anat Embryol
          <year>1985</year>
<volume>171</volume>
<fpage>235</fpage>
<lpage>243</lpage>
<pub-id pub-id-type="doi">10.1007/BF00341418</pub-id>
<pub-id pub-id-type="pmid">3985372</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steward</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>WB</given-names>
</name>
</person-group>
<article-title>Preferential localization of polyribosomes under the base of dendritic spines in granule cells of the dentate gyrus</article-title>
<source/>J Neurosci
          <year>1982</year>
<volume>2</volume>
<fpage>284</fpage>
<lpage>291</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.02-03-00284.1982</pub-id>
<pub-id pub-id-type="pmid">7062109</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tarpey</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Parnau</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Blow</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations in the DLG3 gene cause nonsyndromic X-linked mental retardation</article-title>
<source/>Am J Hum Genet
          <year>2004</year>
<volume>75</volume>
<fpage>318</fpage>
<lpage>324</lpage>
<pub-id pub-id-type="doi">10.1086/422703</pub-id>
<pub-id pub-id-type="pmid">15185169</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<mixed-citation publication-type="other">Volk L, Chiu S-L, Sharma K, Huganir RL (2015) Glutamate synapses in human cognitive disorders. Annu Rev Neurosci. 10.1146/annurev-neuro-071714-033821</mixed-citation>
</ref>
<ref id="CR68">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>von Bohlen Und Halbach</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>Structure and function of dendritic spines within the hippocampus</article-title>
<source/>Ann Anat
          <year>2009</year>
<volume>191</volume>
<fpage>518</fpage>
<lpage>531</lpage>
<pub-id pub-id-type="doi">10.1016/j.aanat.2009.08.006</pub-id>
<pub-id pub-id-type="pmid">19783417</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Aoki</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Elste</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The synthesis of ATP by glycolytic enzymes in the postsynaptic density and the effect of endogenously generated nitric oxide</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>1997</year>
<volume>94</volume>
<fpage>13273</fpage>
<lpage>13278</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.94.24.13273</pub-id>
<pub-id pub-id-type="pmid">9371836</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuste</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>The discovery of dendritic spines by Cajal</article-title>
<source/>Front Neuroanat
          <year>2015</year>
<volume>9</volume>
<fpage>18</fpage>
<pub-id pub-id-type="doi">10.3389/fnana.2015.00018</pub-id>
<pub-id pub-id-type="pmid">25954162</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zehavi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Mandel</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zehavi</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo GRIN1 mutations: an emerging cause of severe early infantile encephalopathy</article-title>
<source/>Eur J Med Genet
          <year>2017</year>
<volume>60</volume>
<fpage>317</fpage>
<lpage>320</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejmg.2017.04.001</pub-id>
<pub-id pub-id-type="pmid">28389307</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>